Pharma has to find new growth pills as Covid booster wears off

September 16, 2022

The pandemic provided a reason to the stock market to be excited about the pharma sector that had been facing lacklustre prospects amid challenges in the US business, USFDA compliance issues, pricing pressure, big-bang acquisitions not working out on expected lines and modest growth in the domestic market.

More To Explore

Finance Ministry eases rules for bonus share issue by companies in FDI-barred sectors

The finance ministry has amended rules, effective June 11, 2025, allowing Indian companies in restricted FDI sectors to issue bonus shares to existing non-resident shareholders,

June 12, 2025

Defying gravity: This smallcap stock surges 22% in just two sessions after BNP Paribas buys stake

Unified Data Tech surged 16% to a 52-week high of ₹387 on strong volumes following a block deal where BNP Paribas acquired over 1 lakh

June 12, 2025

Advertiser Disclosure

Great-investor.com helps users across the globe to find out The latest news, Guides, and Info about finance and investments. Furthermore, our content and research teams do not participate in any advertising planning nor are they permitted access to advertising campaign data.

Disclaimer

It is our organization’s primary mission to provide reviews, commentary, and analysis that are unbiased and objective. While great-investor.com has some data verified by industry participants, it can vary from time to time. Operating as an online business, this site may be compensated through third party advertisers. Our receipt of such compensation shall not be construed as an endorsement or recommendation by great-investor.com, nor shall it bias our reviews, analysis, and opinions. Please see our General Disclaimers for more information

Top10 International FZ LLE | 17th Floor, Creative Tower | 4422 | Fujairah | TRN: 100608946800003